Biotech companies at PMWC 2027

Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website

38 biotech companies are at PMWC 2027 — 43 presentations on the program and 4 with a booth in the exhibit hall. Most represented: Kite Pharma (5 on the program), Allogene Therapeutics (2 on the program), insitro (1 on the program). 1 of them have their own page in this guide. As of Nov 10, 2026.

All 296 organizations at PMWC 2027 →

Topic
Top represented
Showing 1–16 of 38 organizations
OrganizationPMWC 2027 Attendance
Kite Pharma
Santa Monica, CA
Biotech
Gilead company that develops, manufactures and markets CAR T cell therapies for blood cancers.
Track
Wed Jan 27
All day
Panel
Wed Jan 27
11:00am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
AI in Cell Therapy: Research to Commercialization
with Aspen Neuroscience, Genentech, Benchling
Talk
Wed Jan 27
11:30am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
The Bottleneck: Manufacturing at Scale
Panel
Wed Jan 27
1:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
In Vivo Delivery: The Make-or-Break Layer
with Umoja Biopharma, AstraZeneca, RA Capital +1 more
Panel
Wed Jan 27
3:45pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Approved to Effective: Real-World Outcomes, Access, and What CAR-T Still Gets Wrong
with Moffitt Cancer Center, Allogene Therapeutics
Panel
Thu Jan 28
2:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Precision Immunology in Clinical Development
with Eli Lilly, Merck, AltruBio +2 more
Allogene Therapeutics
South San Francisco, CA
Biotech
Clinical-stage developer of allogeneic, off-the-shelf CAR T cell therapies for cancer and autoimmune disease.
Panel
Wed Jan 27
9:45am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Off-the-Shelf Cell Therapies: NK, iPSC, and Allogeneic T Cells, What Wins?
with Stanford University, Nkarta, MD Anderson Cancer Center
Panel
Wed Jan 27
3:45pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Approved to Effective: Real-World Outcomes, Access, and What CAR-T Still Gets Wrong
with Moffitt Cancer Center, Kite Pharma
insitro
South San Francisco, CA
Biotech
Drug discovery company combining machine learning with human genetics and cell data to find and develop new medicines.
PMWC Luminary Award honoree
Track
Fri Jan 29
All day
Track 2: AI in Drug Discovery & Computational Biology
Track chair
Panel
Fri Jan 29
9:30am
Part of Track 2: AI in Drug Discovery & Computational Biology
From Human Evidence to Better Medicines: Choosing the Right Targets
with Bristol Myers Squibb, Valo Health, Novartis +2 more
Panel
Fri Jan 29
1:00pm
Part of Track 2: AI in Drug Discovery & Computational Biology
Fireside: Can AI Build a Better Drug Company?
with Manas AI
CM
CREATE Medicines
Cambridge, MA
Biotech
Clinical-stage biotech, formerly Myeloid Therapeutics, that uses mRNA to program immune cells inside the body against cancer and other diseases.
Talk
Wed Jan 27
11:45am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Is the T Cell the Default We Need to Break in In Vivo CAR Therapy?
Panel
Wed Jan 27
1:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
In Vivo Delivery: The Make-or-Break Layer
with Umoja Biopharma, Kite Pharma, AstraZeneca +1 more
BiotechExhibitor
Clinical-stage biotech developing PSGL-1-targeting immune modulators to rebalance T cells, with a lead program in ulcerative colitis.
Booth
Exhibiting at Booth D1246
Panel
Thu Jan 28
2:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Precision Immunology in Clinical Development
with Eli Lilly, Merck, Kite Pharma +2 more
BiotechExhibitor
Biotech designing targeting peptides with AI to deliver genetic medicines and other therapeutics to specific cells and tissues.
Booth
Exhibiting at Booth A310
Panel
Fri Jan 29
1:55pm
Part of Track 2: AI in Drug Discovery & Computational Biology
Designed Biology Meets Development Reality: What It Takes to Make a Drug
with BigHat Biosciences, Pathos, Nuclera +1 more
Pathos
Chicago, IL
BiotechExhibitor
AI-driven oncology drug developer that uses AI to choose assets, guide portfolio decisions and monitor its clinical trials.
Booth
Exhibiting at Booth B803
Panel
Fri Jan 29
1:55pm
Part of Track 2: AI in Drug Discovery & Computational Biology
Designed Biology Meets Development Reality: What It Takes to Make a Drug
with BigHat Biosciences, Nuclera, Ligandal +1 more
Aprea Therapeutics
Doylestown, PA
Biotech
Clinical-stage oncology biotech developing small molecules that target DNA damage response pathways in cancer cells.
Panel
Thu Jan 28
1:00pm
Part of Track 1: Immunotherapies & Targeted Therapies
Resistance Biology and Adaptive Combination Strategies
with UCSF, MD Anderson Cancer Center, Cell & Gene
Biotech
Developer of RNA interference medicines that silence disease-causing genes, with programs in cardiometabolic, pulmonary and liver disease.
Panel
Fri Jan 29
1:00pm
Part of Track 1: Programmable Genetic Medicines
RNA Editing, Splice Modulation, and Programmable RNA Medicines
with UC San Diego, Cold Spring Harbor Laboratory
Aspen Neuroscience
San Diego, CA
Biotech
Clinical-stage developer of autologous, iPSC-derived dopamine neuron cell therapy for Parkinson's disease.
Panel
Wed Jan 27
11:00am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
AI in Cell Therapy: Research to Commercialization
with Genentech, Benchling, Kite Pharma
BigHat Biosciences
San Mateo, CA
Biotech
Biotech using machine learning and a high-speed wet lab to design antibodies and other protein therapeutics.
Panel
Fri Jan 29
1:55pm
Part of Track 2: AI in Drug Discovery & Computational Biology
Designed Biology Meets Development Reality: What It Takes to Make a Drug
with Pathos, Nuclera, Ligandal +1 more
BioAge Labs
Richmond, CA
Biotech
Clinical-stage biotech developing drugs for metabolic and age-related diseases, discovered from human aging cohort data.
Panel
Fri Jan 29
9:45am
Part of Track 4: Precision Aging, Prevention & Healthspan
Targeting Aging Biology: What Is Actually Druggable Today?
with National University of Singapore, Buck Institute, Rubedo Life Sciences +1 more
Biotech
Clinical-stage developer of CRISPR-edited allogeneic CAR T cell therapies for cancer.
Panel
Fri Jan 29
11:15am
Part of Track 1: Programmable Genetic Medicines
Genome Editing Beyond the First Wave
with Max Planck Unit for the Science of Pathogens, UC San Diego, Editpep
E
Editpep
Biotech
Biotech developing peptide-based, non-viral delivery technology for CRISPR genome editing medicines.
Panel
Fri Jan 29
11:15am
Part of Track 1: Programmable Genetic Medicines
Genome Editing Beyond the First Wave
with Max Planck Unit for the Science of Pathogens, Caribou Biosciences, UC San Diego
G
Genscience
Biotech
Human genetics research company affiliated with the investment firm Deerfield, using genetic evidence to choose drug targets.
Panel
Fri Jan 29
9:30am
Part of Track 2: AI in Drug Discovery & Computational Biology
From Human Evidence to Better Medicines: Choosing the Right Targets
with Bristol Myers Squibb, Valo Health, Novartis +2 more
Biotech
Clinical-stage biotech using generative AI and robotics to discover drugs, with its own pipeline in fibrosis, cancer and other diseases.
Panel
Fri Jan 29
1:20pm
Part of Track 2: AI in Drug Discovery & Computational Biology
From Prediction to Proof: Can AI Change the Odds of Clinical Success?
with RefinedScience, AuraClinical, Kuano +1 more

Explore the full PMWC 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Santa Clara. Leave your work email and we’ll be in touch.

Privacy

Download the full PMWC 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from biotech companies

Tell us what you sell and we’ll find the people at these biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse PMWC 2027 by

Exhibit hall

Not affiliated with or endorsed by PMWC or its organizers. Submit a correction